Abstract. The present study is concerned with the fabrication and characterization of Me2Y substituted hexaferrites, Ba2Me2Fe12-xTxO22 (Me = Co 2+ , Mg 2+ , and Cr 2+ , and T = Fe 3+ , and Ga 3+ ). The samples were prepared by the conventional ball milling technique and sintering at 1200° C. The effect of the choices of Me and T ions on the structural and magnetic properties of the hexaferrites were investigated. XRD patterns, magnetic parameters, and Mössbauer spectra of the Co2Y were consistent with a single phase Y-type hexaferrite. However, the CoCr-Y sample was found to be dominated by the Y-type hexaferrite, and M-type and BaCrO4 minority phases were observed in the XRD pattern of the sample. The small increase in saturation magnetization from about 34 emu/g up to 37.5 emu/g was therefore attributed to the development of the M-type phase. On the other hand,
Molybdenum-zinc substituted hexaferrites were synthesized by high-energy ball milling and subsequent sintering at different temperatures (1100, 1200, and 1300° C). The samples sintered at 1100° C exhibited good hard magnetic properties, although a decrease in saturation magnetization from 70.2 emu/g for the unsubstituted sample down to 57 emu/g for the sample with x = 0.3 was observed. The drop in saturation magnetization results mainly from the presence of secondary nonmagnetic oxides. The samples sintered at temperatures ≥1200° C showed an improvement in saturation magnetization, and a sharp drop in coercivith. This behavior was associated with the development of the W-type hexaferrite, the particle growth, and possibly the spin reorientation transition from easy-axis to easy-plane.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.